Boston Bio Systems Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 7.00 Cr
as on 12-12-2024
- Company Age 29 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 9.00 M
as on 12-12-2024
- Revenue %
(FY 2021)
- Profit -29.65%
(FY 2021)
- Ebitda -33.60%
(FY 2021)
- Net Worth -0.03%
(FY 2021)
- Total Assets -0.01%
(FY 2021)
About Boston Bio Systems
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 7.00 Cr.
The company has closed loans amounting to ₹9.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Boston Bio Systems Limited India are Mandeep Kaur as COMPANY SECRETARY and Manpreet Powani as Cfo. Ghanshyam Gavali, Aashish Dharmadhikari, Seema Baghel, and Three other members serve as directors at the Company.
- CIN/LLPIN
L31100GJ1995PLC025476
- Company No.
025476
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Apr 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Boston Bio Systems?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pratik Patil  | Managing Director | 29-Jan-2024 | Current |
| Mandeep Kaur | Company Secretary | 23-Nov-2024 | Current |
| Manpreet Powani | CFO | 26-Dec-2023 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ghanshyam Gavali | Director | 12-Feb-2024 | Current |
| Aashish Dharmadhikari | Director | 29-Jan-2024 | Current |
| Seema Baghel | Additional Director | 05-Oct-2024 | Current |
| Sadhana Patil | Director | 12-Feb-2024 | Current |
| Swati Dhadve | Director | 29-Jan-2024 | Current |
Financial Performance and Corporate Structure Insights of Boston Bio Systems.
Boston Bio Systems Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 29.65% decrease in profit. The company's net worth dipped by a decrease of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Boston Bio Systems?
In 2021, Boston Bio Systems had a promoter holding of 2.14% and a public holding of 97.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Gujarat State Financial Corporation Creation Date: 09 Aug 1996 | ₹9.00 M | Satisfied |
How Many Employees Work at Boston Bio Systems?
Unlock and access historical data on people associated with Boston Bio Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Boston Bio Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Boston Bio Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
